Position in CVM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$42
-$131 QoQ
Shares Held
41
-24.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,652,503 across 414 Biotechnology names. CVM ranks #391 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in CVM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42 | 41 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $173 | 54 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $215 | 41 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,411 | 1,023 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $93 | 41 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $282 | 1,227 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $490 | 1,227 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,300 | 1,227 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,423 | 1,227 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,343 | 1,227 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $3,337 | 1,227 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,533 | 1,227 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,957 | 1,227 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,113 | 1,342 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,966 | 2,539 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,496 | 2,426 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $37,259 | 8,280 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,027 | 2,806 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $50,488 | 7,111 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $70,929 | 6,454 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $11,006 | 1,268 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $165,165 | 10,859 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $265,451 | 22,766 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $417,779 | 32,767 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $552,174 | 37,009 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $133,044 | 11,529 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||